| Integrated proteogenomic characterization of HBV-related hepatocellular carcinoma Q Gao, H Zhu, L Dong, W Shi, R Chen, Z Song, C Huang, J Li, X Dong, ... Cell 179 (2), 561-577. e22, 2019 | 902 | 2019 |
| Proteogenomic characterization identifies clinically relevant subgroups of intrahepatic cholangiocarcinoma L Dong, D Lu, R Chen, Y Lin, H Zhu, Z Zhang, S Cai, P Cui, G Song, ... Cancer cell 40 (1), 70-87. e15, 2022 | 240 | 2022 |
| Heterogeneous immunogenomic features and distinct escape mechanisms in multifocal hepatocellular carcinoma L Dong, L Peng, L Ma, D Liu, S Zhang, S Luo, J Rao, H Zhu, S Yang, S Xi, ... Journal of hepatology 72 (5), 896-908, 2020 | 161 | 2020 |
| Landscape of infiltrating B cells and their clinical significance in human hepatocellular carcinoma Z Zhang, L Ma, S Goswami, J Ma, B Zheng, M Duan, L Liu, L Zhang, J Shi, ... Oncoimmunology 8 (4), e1571388, 2019 | 141 | 2019 |
| CCL 15 Recruits Suppressive Monocytes to Facilitate Immune Escape and Disease Progression in Hepatocellular Carcinoma LZ Liu, Z Zhang, BH Zheng, Y Shi, M Duan, LJ Ma, ZC Wang, LQ Dong, ... Hepatology 69 (1), 143-159, 2019 | 137 | 2019 |
| Radiomics score: a potential prognostic imaging feature for postoperative survival of solitary HCC patients BH Zheng, LZ Liu, ZZ Zhang, JY Shi, LQ Dong, LY Tian, Z Ding, Y Ji, ... BMC cancer 18, 1-12, 2018 | 134 | 2018 |
| Spatial and temporal clonal evolution of intrahepatic cholangiocarcinoma LQ Dong, Y Shi, LJ Ma, LX Yang, XY Wang, S Zhang, ZC Wang, M Duan, ... Journal of hepatology 69 (1), 89-98, 2018 | 86 | 2018 |
| Genome-Scale CRISPR screen identifies LAPTM5 driving lenvatinib resistance in hepatocellular carcinoma J Pan, M Zhang, L Dong, S Ji, J Zhang, S Zhang, Y Lin, X Wang, Z Ding, ... Autophagy 19 (4), 1184-1198, 2023 | 63 | 2023 |
| Clinical significance of PD-1/PD-Ls gene amplification and overexpression in patients with hepatocellular carcinoma LJ Ma, FL Feng, LQ Dong, Z Zhang, M Duan, LZ Liu, JY Shi, LX Yang, ... Theranostics 8 (20), 5690, 2018 | 62 | 2018 |
| Geospatial immune heterogeneity reflects the diverse tumor–immune interactions in intrahepatic cholangiocarcinoma Y Lin, L Peng, L Dong, D Liu, J Ma, J Lin, X Chen, P Lin, G Song, M Zhang, ... Cancer Discovery 12 (10), 2350-2371, 2022 | 53 | 2022 |
| Splicing Regulator p54nrb/Non–POU Domain–Containing Octamer‐Binding Protein Enhances Carcinogenesis Through Oncogenic Isoform Switch of MYC Box … Z Hu, L Dong, S Li, Z Li, Y Qiao, Y Li, J Ding, Z Chen, Y Wu, Z Wang, ... Hepatology 72 (2), 548-568, 2020 | 53 | 2020 |
| Autoantibody signature in hepatocellular carcinoma using seromics S Zhang, Y Liu, J Chen, H Shu, S Shen, Y Li, X Lu, X Cao, L Dong, J Shi, ... Journal of Hematology & Oncology 13, 1-10, 2020 | 51 | 2020 |
| Multimodule characterization of immune subgroups in intrahepatic cholangiocarcinoma reveals distinct therapeutic vulnerabilities J Lin, Y Dai, C Sang, G Song, B Xiang, M Zhang, L Dong, X Xia, J Ma, ... Journal for Immunotherapy of Cancer 10 (7), e004892, 2022 | 44 | 2022 |
| The distribution of immune cells within combined hepatocellular carcinoma and cholangiocarcinoma predicts clinical outcome BH Zheng, JQ Ma, LY Tian, LQ Dong, GH Song, JM Pan, YM Liu, SX Yang, ... Clinical and translational medicine 10 (1), 45-56, 2020 | 32 | 2020 |
| Efficacy and safety of transcatheter arterial chemoembolization and transcatheter arterial chemotherapy infusion in hepatocellular carcinoma: a systematic review and meta-analysis X Liu, Z Wang, Z Chen, L Liu, L Ma, L Dong, Z Zhang, S Zhang, L Yang, ... Oncology research 26 (2), 231, 2018 | 30 | 2018 |
| Telomere length variation in tumor cells and cancer‐associated fibroblasts: potential biomarker for hepatocellular carcinoma LJ Ma, XY Wang, M Duan, LZ Liu, JY Shi, LQ Dong, LX Yang, ZC Wang, ... The Journal of pathology 243 (4), 407-417, 2017 | 29 | 2017 |
| Proteomics of adjacent-to-tumor samples uncovers clinically relevant biological events in hepatocellular carcinoma H Zhu, Y Lin, D Lu, S Wang, Y Liu, L Dong, Q Meng, J Gao, Y Wang, ... National science review 10 (8), nwad167, 2023 | 24 | 2023 |
| An Inflammatory Checkpoint Generated by IL1RN Splicing Offers Therapeutic Opportunity for KRAS-Mutant Intrahepatic Cholangiocarcinoma M Zhang, Y Huang, J Pan, C Sang, Y Lin, L Dong, X Shen, Y Wu, G Song, ... Cancer Discovery 13 (10), 2248-2269, 2023 | 15 | 2023 |
| An integrative pan‐cancer analysis of the molecular and biological features of glycosyltransferases Y Li, Y Lin, L Aye, L Dong, C Zhang, F Chen, Y Liu, J Fan, Q Gao, H Lu, ... Clinical and Translational Medicine 12 (7), e872, 2022 | 13 | 2022 |
| FUT8 is regulated by miR‐122‐5p and promotes malignancies in intrahepatic cholangiocarcinoma via PI3K/AKT signaling F Chen, Y Li, L Aye, Y Wu, L Dong, Z Yang, Q Gao, S Zhang Cellular Oncology 46 (1), 79-91, 2023 | 12 | 2023 |
